Antibacterial activity of ZnO nanoparticle suspensions on a broad spectrum of microorganisms

FEMS Microbiology Letters

Volumn 279, Issue 1, 2008, Pages 71-76

  Jones, Nicole ^a   Ray, Binata ^a   Ranjit, Koodali T ^b   Manna, Adhar C ^a,c  

^a UNIVERSITY OF SOUTH DAKOTA   (United States)

^b W O Farber Center for Civic Leadership   (United States)

^c SOUTH DAKOTA STATE UNIVERSITY   (United States)

Author keywords

Antibacterial; Staphylococcus aureus; ZnO nanoparticles

Indexed keywords

ALUMINUM OXIDE; CERIUM; COPPER DERIVATIVE; MAGNESIUM OXIDE; METAL OXIDE; NANOPARTICLE; TITANIUM DIOXIDE; ZINC OXIDE;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACILLUS SUBTILIS; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIOSTASIS; CONTROLLED STUDY; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; LIGHT; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STREPTOCOCCUS PYOGENES;

ANTI-BACTERIAL AGENTS; GRAM-POSITIVE BACTERIA; LIGHT; NANOPARTICLES; SUSPENSIONS; ZINC OXIDE;

BACTERIA (MICROORGANISMS); STAPHYLOCOCCUS AUREUS;

EID: 37349033634     PISSN: 03781097     EISSN: 15746968     Source Type: Journal    
DOI: 10.1111/j.1574-6968.2007.01012.x     Document Type: Article

References (30)

1. Berry V, Gole A, Kundu S, Murphy CJ Saraf RF (2005) Deposition of CTAB-terminated nanorods on bacteria to form highly conducting hybrid systems. J Am Chem Soc 127 : 17600 17601.
2. Boyce JM (1997) Epidemiology and prevention of nosocomial infections. The Staphylococci in Human Disease (Crossley KB Archer GL, eds pp. 309 329. Churchill Livingstone, New York.
3. Brayner R, Ferrari-Iliou R, Brivois N, Djediat S, Benedetti MF Fievet F (2006) Toxicological impact studies based on Escherichia coli bacteria in ultrafine ZnO nanoparticles colloidal medium. Nano Lett 6 : 866 870.
4. Cioffi N, Torsi L, Ditaranto N, Tantillo G, Ghibelli L, Sabbatini L, Bleve-Zacheo T, D'Alessio M, Zambonin PG Traversa E (2005) Copper nanoparticle/polymer composites with antifungal and bacteriostatic properties. Chem Mater 17 : 5255 5262.
5. Desselberger U (2000) Emerging and re-emerging infectious diseases. J Infect 40 : 3 15.
6. Furno F, Morley KS, Wong B, Sharp BL, Arnold PL, Howdle SM, Bayston R, Brown PD, Winship PD Reid HJ (2004) Silver nanoparticles and polymeric medical devices: a new approach to prevent infection. J Antimicrob Chemother 54 : 1019 1024.
7. Gaballa A Helmann JD (1998) Identification of a zinc-specific metalloregulatory protein, Zur, controlling zinc transport operons in Bacillus subtilis. J Bacteriol 180 : 5815 5821.
8. Hancook LE Gilmore MS (2000) Pathogenicity of Enterococci. Gram-Positive Pathogens (Fischetti VA, Novick RP, Ferretti JJ, Portnoy DA Rood JI, eds), pp. 251 258. ASM Press, Washington, DC.
9. 2 visible light photocatalyst for destruction of azodyes and bacteria. J Phys Chem B 110 : 4066 4072.
10. Koper OB, Klabunde JS, Marchin GL, Klabunde KJ, Stoimenov P Bohra L (2002) Nanoscale powders and formulations with biocidal activity toward spores and vegetative cells of Bacillus species, viruses, and toxins. Curr Microbiol 44 : 49 55.
11. Kuhn KP, Chaberny IF, Massholder K, Stickler M, Benz VW, Sonntag HG Erdinger L (2003) Disinfection of surfaces by photocatalytic oxidation with titanium dioxide and UVA light. Chemosphere 53 : 71 77.
12. Lewis K Klibanov AM (2005) Surpassing nature: rational design of sterile-surface materials. Trends Biotechnol 23 : 343 348.
13. Lin J, Qiu S, Lewis K Klibanov AM (2002) Bactericidal properties of flat surfaces and nanoparticles derivatized with alkylated polyethylenimines. Biotechnol Prog 18 : 1082 1086.
14. 2+ -responsive regulatory element of Staphylococcus aureus. Microbiol 147 : 1259 1266.
15. Lowy F (1998) Staphylococcus aureus infections. N Engl J Med 339 : 520 532.
16. Ma D, Guan J, Normandin F, Denommee S, Enright G, Veres T Simard B (2006) Multifunctional nano-architecture for biomedical applications. Chem Mater 18 : 1920 1927.
17. Navarre WW Schneewind O (1999) Surface proteins of Gram-positive bacteria and mechanisms of their targeting to the cell wall envelope. Microbiol Mol Biol Rev 63 : 174 229.
18. 2 on pure E. coli and natural bacterial consortium: post-irradiation events in the dark and assessment of the effective disinfection time. Appl Catal B 49 : 99 112.
19. Roselli M, Finamore A, Garaguso I, Britti MS Mengheri E (2003) Zinc oxide protects cultured enterocytes from the damage induced by E. coli. J Nutr 133 : 4077 4082.
20. Rosi NL Mirkin CA (2005) Nanostructures in biodiagnostics. Chem Rev 105 : 1547 1562.
21. Sawai J (2003) Quantitative evaluation of antibacterial activities of metallic oxide powders (ZnO, MgO and CaO) by conductimetric assay. J Microbiol Methods 54 : 177 182.
22. Sondi I Salopak-Sondi B (2004) Silver nanoparticles as antimicrobial agent: a case study on E. coli as a model for Gram-negative bacteria. J Colloid Interface Sci 275 : 177 182.
23. Stoimenov PK, Klinger RL, Marchin GL Klabunde KJ (2002) Metal oxide nanoparticles as bactericidal agents. Langmuir 18 : 6679 6686.
24. 2 thin film photocatalysts. Environ Sci Technol 32 : 726 728.
25. Sunada K, Watanabe T Hashimoto K (2003) Disinfection of surfaces by photocatalytic oxidation with titanium dioxide and UVA light. J Photochem Photobiol A 156 : 227 233.
26. 2 nanoparticles for Escherichia coli. Physico-chemical insight of the cytotoxicity mechanism. Environ Sci Technol 40 : 6151 6156.
27. Tiller JC, Liao CJ, Lewis K Klibanov AM (2001) Designing surfaces that kill bacteria on contact. Proc Natl Acad Sci USA 98 : 5981 5985.
28. Vandenesch F, Naimi T, Enright MC et al 2003) Community-acquired methicillin- resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes. Emerg Infect Dis 9 : 978 984.
29. Xiong A Jayaswal RK (1998) Molecular characterization of a chromosomal determinant conferring resistance to zinc and cobalt ions in Staphylococcus aureus. J Bacteriol 180 : 4024 4029.
30. Zaoutis TE, Toltzis P, Chu J, Abrams T, Dul M, Kim J, McGowan KL Coffin SF (2006) Clinical and molecular epidemiology of community-acquired methicillin-resistant Staphylococcus aureus infections among children with risk factors for health care-associated infection: 2001-2003. Pediatr Infect Dis J 25 : 343 348.